Insider · CIK 0001877680

Ellis Andrea

Reports to the SEC for 1 company · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001877680

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-09	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−17.2K sh	—	—	17,167
2026-07-09	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−17.2K sh	$84.00	−$1.44M	22,579
2026-07-09	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+17.2K sh	$16.75	+$288K	39,746
2026-06-22	BBIOBridgeBio Pharma, Inc.A Award	Director	AAward	+3,990 sh	—	—	22,579
2026-06-22	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,277 sh	—	—	5,277
2026-03-04	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−64.9K sh	—	—	0
2026-03-04	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+64.9K sh	$8.45	+$549K	83,510
2026-03-04	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−64.9K sh	$64.87	−$4.21M	18,589
2025-08-05	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−17.2K sh	—	—	34,334
2025-08-05	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−17.2K sh	$49.00	−$841K	18,589
2025-08-05	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+17.2K sh	$16.75	+$288K	35,756
2025-06-20	BBIOBridgeBio Pharma, Inc.A Award	Director	AAward	+6,589 sh	—	—	18,589
2025-06-20	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,425 sh	—	—	8,425
2025-04-14	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$8.45	+$84.5K	22,000
2025-04-14	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	64,921
2025-04-14	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−10K sh	$35.00	−$350K	12,000
2025-04-01	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$8.45	+$253K	42,000
2025-04-01	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−30K sh	$34.05	−$1.02M	12,000
2025-04-01	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	74,921
2024-06-21	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,014
2023-06-21	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+51.5K sh	—	—	51,501
2022-06-22	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+105K sh	—	—	104,921
2022-03-15	BBIOBridgeBio Pharma, Inc.P Purchase	Director	PPurchase	+12K sh	$8.39	+$101K	12,000
2021-08-17	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+49.9K sh	—	—	49,869

Recent filings

Accepted (ET)
Jul 134
Ellis Andrea0001470831-26-000709
SEC(opens sec.gov)
Jun 244
Ellis Andrea0001470831-26-000630
SEC(opens sec.gov)
Mar 64
Ellis Andrea0001470831-26-000252
SEC(opens sec.gov)
Aug 74
Ellis Andrea0000950170-25-105185
SEC(opens sec.gov)
Jun 244
Ellis Andrea0000950170-25-089673
SEC(opens sec.gov)
Apr 164
Ellis Andrea0000950170-25-054883
SEC(opens sec.gov)
Apr 34
Ellis Andrea0000950170-25-050584
SEC(opens sec.gov)
Jun 254
Ellis Andrea0000950170-24-077443
SEC(opens sec.gov)

Companies

BridgeBio Pharma, Inc.DirectorBBIO

Address

C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR., SUITE 250

PALO ALTO, CA, 94304